Cargando…
miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells
Objective: Hormonal therapy is an important component of first line of treatment for breast cancer. Response to hormonal therapy is influenced by the progesterone receptor (PR)-status of breast cancer patients. However as an early effect, exposure to progesterone decreases expression of PR in breast...
Autores principales: | Godbole, Mukul, Chandrani, Pratik, Gardi, Nilesh, Dhamne, Hemant, Patel, Kuldeep, Yadav, Neelima, Gupta, Sudeep, Badwe, Rajendra, Dutt, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678702/ https://www.ncbi.nlm.nih.gov/pubmed/28876975 http://dx.doi.org/10.1080/15384047.2017.1373216 |
Ejemplares similares
-
Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1–NDRG1 axis in both PR-positive and -negative breast cancer cells
por: Godbole, Mukul, et al.
Publicado: (2018) -
Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status - a short report
por: Godbole, Mukul, et al.
Publicado: (2017) -
Deciphering the mechanisms of action of progesterone in breast cancer
por: Chakravorty, Gaurav, et al.
Publicado: (2023) -
Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer
por: Yadav, Neelima, et al.
Publicado: (2022) -
Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer
por: Upadhyay, Pawan, et al.
Publicado: (2016)